Journal of Surgical Research
Volume 155, Issue 1 , Pages 32-39 , July 2009

Implication of Protein Kinase A for a Hepato-Protective Mechanism of Milrinone Pretreatment

  • Kohei Satoh, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Makoto Kume, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Gastroenterological Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-5843, Japan.
    • ,
  • Yuki Abe, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Hiroshi Uchinami, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Siarhei V. Yakubouski, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • Department of Surgical Disease No. 1, Belarussian State Medical University, Minsk, Republic of Belarus
    • ,
  • Tomokazu Takahashi, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Tsutomu Sato, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Yuzo Yamamoto, M.D.

      Affiliations

    • Department of Gastroenterological Surgery, Akita University School of Medicine, Akita, Japan

Received 8 March 2008

References 

  1. Kume M, Banafsche R, Yamamoto Y, et al. Dynamic changes of post-ischemic hepatic microcirculation improved by a pretreatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res. 2006;136:209
  2. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol. 2006;147:S252
  3. Manganiello VC. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. J Mol Cell Cardiol. 1987;19:1037
  4. Watanabe T, Satoo H, Kohara K, et al. Orthovanadate stimulates cAMP phosphodiesterase 3 activity in isolated rat hepatocytes through mitogen-activated protein kinase activation dependent on cAMP-dependent protein kinase. Biol Pharm Bull. 2004;27:789
  5. Suttorp N, Weber U, Welsch T, et al. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J Clin Invest. 1993;91:1421
  6. Feije MAH, Ansink K, Vanschoonbeek K, et al. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3. Biochem Pharmacol. 2004;67:1559
  7. Kopperud R, Krakstad C, Selheim F, et al. cAMP effector mechanisms. Novel twists for an “old” signaling system. FEBS Lett. 2003;546:121
  8. Cullen KA, McCool J, Anwer MS, et al. Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. Am J Physiol Gastrointest Liver Physiol. 2004;287:G334
  9. Tiwari S, Felekkis K, Moon E-Y, et al. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood. 2004;103:2661
  10. Schoelch C, Kuhlmann J, Gossel M, et al. Characterization of adenosine-A1 receptor-mediated antilipolysis in rats by tissue microdialysis, 1H-spectroscopy, and glucose clamp studies. Diabetes. 2004;53:1920
  11. Gjertsen BT, Mellgren G, Otten A, et al. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1β action. J Biol Chem. 1995;270:20599
  12. Dostmann WRG, Taylor SS, Genieser H-G, et al. Probing the cyclic nucleotide binding sites of cAMP-dependent protein kinases I and II with analogs of adenosine 3',5'-cyclic phosphorothioates. J Biol Chem. 1990;265:10484
  13. Yokozaki H, Tortora G, Pepe S, et al. Unhydrolysable analogues of adenosine 3':5'-monophosphate demonstrating growth inhibition and differentiation in human cancer cells. Cancer Res. 1992;52:2504
  14. Said HM, Ortiz A, Ma TY. A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: Regulation by a PKA-mediated pathway. Am J Physiol Cell Physiol. 2003;285:C1219
  15. Banerjee DK, Carrasquillo EA, Hughey P, et al. In vitro phosphorylation by cAMP-dependent protein kinase up-regulates recombinant Saccharomyces cerevisiae mannosylphosphodolichol synthase. J Biol Chem. 2005;280:4174
  16. Arai M, Thurman RG, Lemasters JJ. Contribution of adenosine A(2) receptors and cyclic adenosine monophosphate to protective ischemic preconditioning of sinusoidal endothelial cells against storage/reperfusion injury in rat livers. Hepatology. 2000;32:297
  17. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15
  18. Jaeschke H. Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1083
  19. Foey AD, Field S, Ahmed S, et al. Impact of VIP and cAMP on the regulation of TNF-α and IL-10 production: Implications for rheumatoid arthritis. Arthritis Res Ther. 2003;5:R317
  20. Pradines-Figueres A, Reatz CRH. Processing and secretion of tumor necrosis factor-α in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate. J Biol Chem. 1992;267:23261
  21. Gilles S, Zahler S, Welsch U, et al. Release of TNF-α during myocardial reperfusion depends on oxidative stress and is prevented by mast cell stabilizers. Cardiovasc Res. 2003;60:608
  22. Németh ZH, Szabó C, Haskó G, et al. Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur J Pharmacol. 1997;339:215
  23. Akbar S, Minor T. Significance and molecular targets of protein kinase A during cAMP-mediated protection of cold stored liver grafts. Cell Mol Life Sci. 2001;58:1708
  24. Jaeschke H, Gujral JS, Bajt ML. Apoptosis and necrosis in liver disease. Liver Int. 2004;24:85
  25. Malhi H, Gores GJ, Lemasters JJ. Apoptosis and necrosis in the liver: A tale of two deaths?. Hepatology. 2006;43:S31
  26. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125:1246

PII: S0022-4804(08)00460-5

doi: 10.1016/j.jss.2008.07.004

Journal of Surgical Research
Volume 155, Issue 1 , Pages 32-39 , July 2009

Article Tools

* Image Usage & Resolution